logo

For the Inventor, By the Inventor

Arlesheim, Switzerland

Bruno Kamber

USPTO Granted Patents = 13

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 194(Granted Patents)


Location History:

  • Basel, CH (1976 - 1981)
  • Arlesheim, CH (1980 - 1986)

Company Filing History:

goldMedal13 out of 6,850 
 
Ciba-geigy Corporation
 patents

Years Active: 1976-1986

Loading Chart...
13 patents (USPTO):Explore Patents
1. 4616002 - Dihydro pyridine compounds, compositions and use (1986-10-07),
2. 4603120 - Cyclic octapeptides and pharmaceutical preparations thereof, as well as (1986-07-29),
3. 4439425 - Peptide derivatives (1984-03-27),
4. 4369179 - Acylpeptides (1983-01-18),
5. 4358439 - Cyclooctapeptides (1982-11-09),
6. 4328214 - Cyclopeptides and pharmaceutical preparations thereof and also processes (1982-05-04),
7. 4316890 - Peptides and processes for the manufacture thereof (1982-02-23),
8. 4271068 - Process for the manufacture of cystine-containing peptides (1981-06-02),
9. 4238481 - Novel cyclopeptides (1980-12-09),
10. 4159981 - Peptides and process for their manufacture (1979-07-03),
11. 3994871 - Process for the manufacture of peptides containing cystine (1976-11-30),
12. 3956260 - Hypocalcaemic peptides and processes for their manufacture (1976-05-11),
13. 3934008 - N-acyl and desamino human calcitonin and analogs thereof (1976-01-20),

Title: Bruno Kamber: Innovator in Pharmaceutical Chemistry

Introduction

Bruno Kamber is a distinguished inventor based in Arlesheim, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 13 patents. His work primarily focuses on the development of novel compounds with therapeutic applications.

Latest Patents

Among his latest patents, Kamber has developed dihydro pyridine compounds, which are characterized by their cardiovascular properties, particularly in reducing blood pressure. These compounds are defined by a complex formula that includes various radicals and functional groups, showcasing his expertise in organic chemistry. Additionally, he has worked on cyclic octapeptides, which are important in pharmaceutical preparations, further demonstrating his innovative approach to drug development.

Career Highlights

Kamber's career is marked by his association with Ciba-Geigy Corporation, a leading company in the pharmaceutical industry. His work has not only advanced the understanding of chemical compounds but has also contributed to the development of new medications that can improve patient outcomes.

Collaborations

Throughout his career, Kamber has collaborated with notable colleagues such as Peter Sieber and Werner Rittel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Bruno Kamber's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new therapeutic agents that can benefit society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…